Follistatin 315 Peptide Vial

Follistatin 315 Peptide Vial 1mg

New Zealand Direct Sarms does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended to be used as a drug, stimulant or for use in any food products.

Research has suggested that Follistatin 315 peptide vial 1mg is a glycoprotein, meaning that the compound contains sugars and proteins. It is naturally-occurring and produced in different forms that play distinct roles in the body.  New Zealand Clinic trials have evidenced Follistatin 315 as one of the primary forms of the glycoprotein and is found in the bloodstream.

This variety of follistatin influences the development of the muscle tissue, which is why it’s considered one of the most suitable forms to get as a supplement. Follistatin 315 peptide vial is growing as one of the popular supplements on the bodybuilding market.

Benefits of Follistatin 315 Peptide Vial 1mg

Building Muscle Mass

A New Zealand study of follistatin 315 on non-human primates showed that the glycoprotein contributed to Increased muscle mass. The compound boosts the development of muscle size and strength. However, no conclusive research shows if similar results are replicated in human subjects.

A study of follistatin derived from egg yolk had positive outcomes in make subjects regarding building muscle mass. The subjects used the supplement as part of an exercise regimen, combining it with resistance training. Other various tests of the compound on rodents resulted in larger muscles due to the improved development of muscle cells.

Retaining Muscle Mass

Building muscles and retaining them are two different things. Follistatin 315 peptide vial does both. Several studies have been carried out to analyse the effect of the glycoprotein on certain muscular disorders. When tested, Follistatin showed that subjects improved their muscle strength over a particular period.

The compound is capable of inhibiting myostatin. Through the type IIB activin receptor, the myostatin pathway hinders muscle development. Inhibiting this pathway leads to increased strength and hypertrophy. Follistatin is one for the most effective myostatin antagonists. By keeping this protein in check, the body can develop muscle cells without experiencing significant muscle loss.

Hair growth

New Zealand Researchers have confirmed the efficacy of Follistatin 315 peptide vial as a treatment for baldness. Follistatin 315 1mg was shown in a study on 26 men with male-pattern baldness to increase the density and thickness of hair on the head. These results persisted for up to a year after just one application of the hair loss treatment follistatin 315.

Clinic studies have shown that follistatin 315 peptide is an effective treatment for male pattern baldness. That it works so well with only one injection and doesn’t need to be repeated throughout the year is particularly intriguing.

However, more thorough research is required to show conclusively that the hormone peptide Follistatin 315 aids in the treatment of male-pattern baldness.

Fat Loss

There is insufficient evidence to support the use of follistatin 315 in the treatment of obesity. However, according to two separate studies, peptides can help mice burn more fat and shrink their fat cells. The follistatin 315 peptide vial fat loss treatment was effective even when mice were fed a high-calorie diet specifically designed to make them fatter.

Fertility

A role for Follistatin 315 peptide vial 1mg in reproductive health can be ascribed to the virus. Users who consume this protein appear to be more fertile. In a study of seven pregnant women, higher follistatin levels 315 in the third trimester were linked to a healthy childbirth. Actins, which are involved in many aspects of reproductive health, can also be inhibited by Follistatin 315.

Follistatin 315 is highly concentrated in male seminal fluid. However, it has not been demonstrated that the presence of this substance affects sperm count. Follicilogenesis, the release of eggs from the ovaries during ovulation, is aided by follistatin 315 in females. During menopause, follistatin 315 levels tend to decline, but supplementation with follistatin 315 peptide vial can help restore them.

Rheumatoid arthritis

Follistatin 315 has been shown in studies on mice to reduce joint inflammation and cartilage degeneration significantly. However, there is no evidence that this peptide has the same effects in humans as in animals and cells. Follistatin 315 peptide vial, on the other hand, shows promise as a potential anti-inflammatory drug in further clinical trials.

Cancer research

Follistatin 315 peptide vial may also play a role in preventing cancer growth, according to recent scientific research. It has already been found that follistatin can significantly positively impact several types of cancer: lung, breast, ovarian and liver cancers.

Follistatin 315, on the other hand, may have a negative impact on other forms of cancer, such as prostate, oesophagus, stomach and skin cancers. The anti-cancer effects of Follistatin 315 are still being investigated. However, there is a reason for optimism.

According to a New Zealand study that examined tissue samples, the protein was found in higher concentrations in breast cancer survivors. This suggests that follistatin-315 peptide vial 1mg may offer protection against breast cancer through its protective effects. The survival rate of breast cancer cells was reduced, while at the same time, the spread of cancerous cells was prevented in other cell studies.

References:

[1] Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Rodino-Klapac LR, Tucker D, Shilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PM, Clark KR, Sahenk Z, Mendell JR, Kaspar BK. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med. 2009 Nov 11;1(6):6ra15.

[2] Lee SJ. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One. 2007 Aug 29;2(8):e789.

[3] Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, Wright JF, Barker C, Ehrmantraut G, Holmstrom J, Trowell B, Gertz B, Jiang MS, Sebald SM, Matzuk M, Li E, Liang LF, Quattlebaum E, Stotish RL, Wolfman NM. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18117-22.

Follistatin 315 Peptide Vial Specifications:

Sequence: G NCWLRQAKNG RCQVLYKTEL SKEECCSTGR LSTSWTEEDV NDNTLFKWMI FNGGAPNCIP CKETCENVDC GPGKKCRMNK KNKPRCVCAP DCSNITWKGP VCGLDGKTYR NECALLKARC KEQPELEVQY QGRCKKTCRD VFCPGSSTCV VOCITNNAYCV TCNRICPEPA SSEQYLCGND GVTYSSACHL RKATCLLGRS IGLAYEGKCI KAKSCEDIOC TGGKKCLWDF KVGRGRCSLC DELCPDSKSD EPVCASDNAT YASECAMKEA ACSSGVLLEV KHSGSCNSIS EDTEEEEEDE DODYSFPISS ILEW

Molecular Formula: C1350H2153N405O433S39

Molecular weight: 3780 g/mol

Direct Sarms also offers premium grade Follistatin 344 for sale, discover about this peptide here.

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.